Feb. 11, 2025 — A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way ...

Feb. 11, 2025 — A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way ...

DiADeM is a tool to support GPs in diagnosing dementia for people living with advanced dementia in a care home setting. It has been developed by the Yorkshire and Humber Dementia Strategic Clinical ...

Friends or family members, including those who are caring for the person, can also be in denial and find a dementia diagnosis difficult to accept. It is not only people with dementia who may not ...

2-Year U.S. Treasury Note Continuous Contract $102.871 0.121 0.12% 5-Year U.S. Treasury Note Continuous Contract $106.758 0.281 0.26% 10-Year U.S. Treasury Note Continuous Contract $109.578 0.406 ...

Short-term memory loss can be a sign of early-stage Alzheimer's disease. It can manifest as difficulty creating new memories or problems retrieving them. For example, someone with early Alzheimer's ...

Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined Alzheimer’s Research UK in 2013 and has overseen significant growth in income in recent years, which has ...

These pages include facts and statistics about dementia in the UK, what causes dementia and more information about what dementia research has achieved. Find out the 10 most important facts and ...

DAX Futures 22258.00-60.00-0.27% ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...